Cure My Disease

Don't miss your cure!

 Log in / Sign up

A 45-minute chat could change how advanced cancer patients face tough decisions

NCT ID NCT07789093

Symptom relief Sponsor: Singapore General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

Researchers at Singapore General Hospital are testing whether a one-on-one coaching session, called CONCORD, helps patients with advanced cancer prepare for serious illness conversations with their doctors. The session, led by a trained lay coach, covers topics like understanding the illness, fears, goals of care, and treatment expectations. The trial compares patients who receive this coaching with those who get usual care, measuring the quality of those conversations, decision-making, and quality of life. The goal is to see if this simple, brief intervention can make a meaningful difference for patients facing palliative procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A one-on-one coaching session delivered by a lay healthcare provider to help patients prepare for serious illness conversations and treatment decisions.
What this could lead to
If it works, this coaching approach could help advanced cancer patients feel more prepared for difficult conversations, make decisions that match their goals, and improve their quality of life.
What could go wrong
This is a single-site trial with 220 participants, and the coaching is brief, so any benefits may be modest or not apply to all patients. The outcome depends on how well patients and caregivers engage with the session.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 220 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: (i) Patient: 1. Aged 21 or above; 2. Diagnosis of advanced cancer, i.e. stage 3 or 4 solid organ 3. Consulted for palliative surgery or other interventions, i.e. procedures aimed at relieving symptoms and improving quality of life 4. Able to speak English or Mandarin; (ii) Caregiver 1. Aged 21 or above; 2. Self-endorsed or identified by the enrolled patient as an unpaid spouse/partner, relative or friend who knows them well and who provides regular care, who does not have to live in the same dwelling 3. Able to speak English or Mandarin. Exclusion Criteria: (i). Patient 1. Patient refusal, 2. Active mental illness or severe dementia, or being certified unfit to make medical decision by a specialist physician, 3. Pregnant Women (ii). Caregiver 1. Self-reported severe mental illness, dementia, active suicidal ideation, uncorrected hearing loss; 2. Unable to complete caregiver-reported outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Advanced cancer Palliative care

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Singapore General Hospital

    RECRUITING

    Singapore, 169608, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.